S. Parker

Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers.

J. Maguire, D. Doolan, P. Hobart, 2000, Vaccine.

Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine

S. Hoffman, S. Hoffman, H. Horton, 2001, Gene Therapy.

Plasmid DNA malaria vaccine: tissue distribution and safety studies in mice and rabbits.

S. Hoffman, P. Hobart, S. Parker, 1999, Human gene therapy.

Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection.

S. Hoffman, P. Hobart, S. Parker, 1999, Human gene therapy.

A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.

D. Kaslow, D. Galloway, P. Hobart, 2004, Proceedings of the National Academy of Sciences of the United States of America.